CYTK
Cytokinetics Inc
NASDAQ: CYTK · HEALTHCARE · BIOTECHNOLOGY
$59.58
-1.83% today
Updated 2026-04-29
Market cap
$7.54B
P/E ratio
—
P/S ratio
85.64x
EPS (TTM)
$-6.54
Dividend yield
—
52W range
$29 – $71
Volume
1.9M
Cytokinetics Inc (CYTK) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-9.3%
Last 4 quarters
Revenue YoY growth
+4.9%
Most recent quarter
EPS YoY growth
-19.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.2%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-7.9%
2026-02-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-24 | $-1.50 | +3.8% | $68.26 | $62.89 | -7.9% |
| 2025-11-05 | $-2.55 | -62.4% | $59.62 | $60.30 | +1.1% |
| 2025-08-07 | $-1.12 | +21.1% | $35.14 | $34.11 | -2.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.56 | $-1.50 | +3.8% | $17.75M | +4.9% |
| 2025-09-30 | $-1.57 | $-2.55 | -62.4% | $1.94M | +318.1% |
| 2025-06-30 | $-1.42 | $-1.12 | +21.1% | $66.77M | +26714.9% |
| 2025-03-31 | $-1.36 | $-1.36 | +0.2% | $1.58M | +89.1% |
| 2024-12-31 | $-1.17 | $-1.26 | -7.3% | $16.93M | +912.4% |
| 2024-09-30 | $-1.25 | $-1.36 | -8.8% | $463000.00 | +22.5% |
| 2024-06-30 | $-1.06 | $-1.31 | -23.6% | $249000.00 | -71.3% |
| 2024-03-31 | $-1.14 | $-1.33 | -16.7% | $835000.00 | — |
| 2023-12-31 | $-0.97 | $-1.38 | -42.3% | $1.67M | — |
| 2023-09-30 | $-0.74 | $-1.35 | -82.4% | $378000.00 | — |
| 2023-06-30 | $-1.15 | $-1.34 | -16.5% | $867000.00 | — |
Frequently asked questions
Has Cytokinetics Inc beaten earnings estimates?
Cytokinetics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -9.3% over the last 4 quarters.
How does CYTK stock react to earnings?
CYTK stock has moved an average of -3.2% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Cytokinetics Inc's revenue growth rate?
Cytokinetics Inc reported year-over-year revenue growth of +4.9% in its most recent quarter, with EPS growing -19.0% year-over-year.